ArticleNeurobiology of pain (Cambridge, Mass.)
Biophysical dissection of nociceptor hyperexcitability caused by a Nav1.8 gain-of-function mutation linked to severe pain.
Article in Neurobiology of pain (Cambridge, Mass.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Voltage-gated sodium channel Nav1.8 is highly expressed in nociceptors, where it plays a critical role in sustaining repetitive action potential (AP) firing. Gain-of-function Nav1.8 mutations that increase nociceptor excitability have been identified in patients with painful peripheral neuropathy, but the biophysical mechanisms by which they confer nociceptor hyperexcitability are incompletely understood. Here we carry out a high-resolution dissection of the functional consequences of a Nav1.8 mutation (G1662S) identified in human subjects with severe neuropathic pain, using dynamic clamp modeling in small dorsal root ganglion (DRG) neurons. While Nav1.8WT/GS conductance did not alter resting membrane potential, rheobase, or single AP threshold, it produced a marked hyperexcitability during repetitive firing. Nav1.8WT/GS neurons generated nearly twice as many APs as wild-type controls in response to suprathreshold depolarization, an effect attributable to increased sodium charge transfer across successive spikes. Charge analysis revealed that the GS mutation disproportionately enhanced suprathreshold sodium influx, supporting greater AP fidelity without adaptation. Biophysical dissection showed that this excitability phenotype arises from frequency-dependent mechanisms: at lower firing frequencies, the depolarizing shift in steady-state inactivation increases channel availability and contributes to G1662S-mediated hyperexcitability, whereas at higher firing frequencies both the depolarized voltage-dependence of inactivation and the accelerated recovery from inactivation further sustain G1662S hyperexcitability. Together, these properties enable Nav1.8WT/GS neurons to maintain enhanced firing across a broad range of frequencies, in contrast to wild-type nociceptors that typically adapt faster. These findings provide mechanistic insight into Nav1.8-driven hyperexcitability and highlight Nav1.8 as a therapeutic target for genetic and acquired pain syndromes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.